Silexion Therapeutics Corp
SLXN
$3.78
$0.051.34%
NASDAQ
| 12/31/2024 | 09/30/2024 | 03/31/2024 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -74.17% | -- | -- | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 188.36% | -- | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | 97.96% | -- | -- | ||
| Total Current Assets | -54.81% | -- | -- | ||
|
|
|||||
| Total Current Assets | -54.81% | -- | -- | ||
| Net Property, Plant & Equipment | 126.72% | -- | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 76.67% | -- | -- | ||
| Total Assets | -45.53% | -- | -- | ||
|
|
|||||
| Total Accounts Payable | 191.22% | -- | -- | ||
| Total Accrued Expenses | -8.63% | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 41.07% | -- | -- | ||
| Total Finance Division Other Current Liabilities | -99.00% | -- | -- | ||
| Total Other Current Liabilities | -99.00% | -- | -- | ||
| Total Current Liabilities | 60.43% | -- | -- | ||
|
|
|||||
| Total Current Liabilities | 60.43% | -- | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 523.73% | -- | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | 203.86% | -- | -- | ||
|
|
|||||
| Common Stock & APIC | 246.40% | -- | -- | ||
| Retained Earnings | -61.33% | -- | -- | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | 74.22% | -- | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | 74.22% | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -232.92% | -- | -- | ||
|
|
|||||